BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34987612)

  • 1. Application of Tumor Burden Score for predicting conversion outcome in patients with initially unresectable colorectal liver metastases after first-line systemic therapy.
    Peng J; Liu Y; Li W; Lin Y; Sun H; Pan Z; Wu X; Fan W; Lin J
    Therap Adv Gastroenterol; 2021; 14():17562848211066206. PubMed ID: 34987612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel score system for predicting conversion to no evidence of Disease (C-NED) in initially unresectable colorectal cancer liver metastases.
    Li W; Zhou J; Zhang T; Tai Y; Xu Y; Bai Y; Jiang Y; Lu Z; Li L; Huang J; Pan Z; Wu X; Peng J; Lin J
    Am J Cancer Res; 2022; 12(4):1648-1659. PubMed ID: 35530285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of total tumor volume reduction ratio in initially unresectable colorectal liver metastases after first-line systemic treatment.
    He J; Li W; Zhou J; Sun H; Zhou C; Liu Y; Quan T; Fan W; Pan Z; Lin J; Peng J
    Eur J Radiol; 2023 Aug; 165():110950. PubMed ID: 37437437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic factors affecting the success of conversion chemotherapy in patients with unresectable liver metastases from initially colorectal cancer].
    Zhang WL; Zhou C; Deng YX; Hou ZL; Zhang LJ; Lin JZ; Pan ZZ; Lu ZH; Peng JH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jan; 25(1):56-62. PubMed ID: 35067035
    [No Abstract]   [Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy weakens the prognostic value of the pathological tumor burden score for colorectal cancer liver metastases.
    Liao L; Sun H; He J; Liu Y; Pan Z; Wu X; Fan W; Peng J; Li C
    BMC Surg; 2023 Sep; 23(1):271. PubMed ID: 37689651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score.
    Yonekawa Y; Uehara K; Mizuno T; Aiba T; Ogura A; Mukai T; Yokoyama Y; Ebata T; Kodera Y; Nagino M
    Int J Clin Oncol; 2021 Jan; 26(1):126-134. PubMed ID: 33074351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic utility of the "Tumor Burden Score" based on preoperative radiographic features of colorectal liver metastases.
    Sasaki K; Margonis GA; Andreatos N; Zhang XF; Buettner S; Wang J; Deshwar A; He J; Wolfgang CL; Weiss M; Pawlik TM
    J Surg Oncol; 2017 Sep; 116(4):515-523. PubMed ID: 28543544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Tumor Burden Score: A New "Metro-ticket" Prognostic Tool For Colorectal Liver Metastases Based on Tumor Size and Number of Tumors.
    Sasaki K; Morioka D; Conci S; Margonis GA; Sawada Y; Ruzzenente A; Kumamoto T; Iacono C; Andreatos N; Guglielmi A; Endo I; Pawlik TM
    Ann Surg; 2018 Jan; 267(1):132-141. PubMed ID: 27763897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
    Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
    J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylated ctDNA predicts early recurrence risk in patients undergoing resection of initially unresectable colorectal cancer liver metastases.
    Chen ZG; Ji XM; Xu YX; Fong WP; Liu XY; Liang JY; Tan Q; Wen L; Cai YY; Wang DS; Li YH
    Ther Adv Med Oncol; 2024; 16():17588359241230752. PubMed ID: 38425989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of a novel biomarker combining DNA ploidy and tumor burden score for initially resectable liver metastases from patients with colorectal cancer.
    Peng J; Li W; Fan W; Zhang R; Li X; Xiao B; Dong Y; Wan D; Pan Z; Lin J; Wu X
    Cancer Cell Int; 2021 Oct; 21(1):554. PubMed ID: 34688293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of margin status and tumour burden determines survival after resection of colorectal liver metastases: A retrospective cohort study.
    Mao R; Zhao JJ; Bi XY; Zhang YF; Li ZY; Zhou JG; Zhao H; Cai JQ
    Int J Surg; 2018 May; 53():371-377. PubMed ID: 29229309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
    Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
    Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Evaluation of Relapse Risk (CERR) Score for Colorectal Liver Metastases: Development and Validation.
    Chen Y; Chang W; Ren L; Chen J; Tang W; Liu T; Jian M; Liu Y; Wei Y; Xu J
    Oncologist; 2020 Jul; 25(7):e1031-e1041. PubMed ID: 32181531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion strategies with chemotherapy plus targeted agents for colorectal cancer liver-only metastases: A systematic review.
    Bolhuis K; Kos M; van Oijen MGH; Swijnenburg RJ; Punt CJA
    Eur J Cancer; 2020 Dec; 141():225-238. PubMed ID: 33189037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher Tumor Burden Neutralizes Negative Margin Status in Hepatectomy for Colorectal Cancer Liver Metastasis.
    Oshi M; Margonis GA; Sawada Y; Andreatos N; He J; Kumamoto T; Morioka D; Wolfgang CL; Tanaka K; Weiss MJ; Endo I
    Ann Surg Oncol; 2019 Feb; 26(2):593-603. PubMed ID: 30483976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kirsten rat sarcoma (KRAS) oncogene mutation predicts magnitude of response and outcomes in hepatic arterial infusion pump therapy of unresectable colorectal liver metastases.
    Kolbeinsson HM; Preihs R; Bengel A; Chandana S; Assifi MM; Chung MH; Wright GP
    J Gastrointest Oncol; 2022 Feb; 13(1):163-170. PubMed ID: 35284135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion therapy combined with individualized surgical treatment strategy improves survival in patients with colorectal cancer liver metastases.
    Ma R; Li T
    Int J Clin Exp Pathol; 2021; 14(3):314-321. PubMed ID: 33786148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating Efficacy of Conversion Therapy on Patients with Initially Unresectable Colorectal Cancer Liver Metastases by using MRI: Development of a Predictive Score.
    Liu J; Tang W; Ye L; Miao G; Zeng M; Liu L
    Acad Radiol; 2024 May; ():. PubMed ID: 38734578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.
    Beppu T; Miyamoto Y; Sakamoto Y; Imai K; Nitta H; Hayashi H; Chikamoto A; Watanabe M; Ishiko T; Baba H
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S405-13. PubMed ID: 24570379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.